NEU neuren pharmaceuticals limited

Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-87

  1. 2,558 Posts.
    lightbulb Created with Sketch. 2664
    Sill.According to the company’s accounts there are only 2,5000,000 loan funded share outstanding at the 31st of December 2018 .The loan funded shares vesting conditions had to be exercised by 31st of March 2019.(date now passed ).I have not seen any documentation on the shares being exercised and issued so I presume that they will be cancelled in due course unless the directors have extended the time frame for exercising the loan funded shares .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.